EP1242443A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1242443A4
EP1242443A4 EP00990231A EP00990231A EP1242443A4 EP 1242443 A4 EP1242443 A4 EP 1242443A4 EP 00990231 A EP00990231 A EP 00990231A EP 00990231 A EP00990231 A EP 00990231A EP 1242443 A4 EP1242443 A4 EP 1242443A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00990231A
Other languages
German (de)
English (en)
Other versions
EP1242443A1 (fr
Inventor
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Xiaohong B Qian
Feiyan Ren
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Ryle Goodrich
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1242443A1 publication Critical patent/EP1242443A1/fr
Publication of EP1242443A4 publication Critical patent/EP1242443A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00990231A 1999-12-23 2000-12-26 Nouveaux acides nucleiques et polypeptides Withdrawn EP1242443A4 (fr)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US662191 1991-02-28
US47127599A 1999-12-23 1999-12-23
US471275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US488725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US552317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US598042 2000-07-09
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US620312 2000-07-19
US653450 2000-08-03
US65345000A 2000-08-31 2000-08-31
US66219100A 2000-09-14 2000-09-14
US69303600A 2000-10-19 2000-10-19
US693036 2000-10-19
US72734400A 2000-11-29 2000-11-29
WOPCT/US72/07344 2000-11-29
PCT/US2000/034263 WO2001053312A1 (fr) 1999-12-23 2000-12-26 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1242443A1 EP1242443A1 (fr) 2002-09-25
EP1242443A4 true EP1242443A4 (fr) 2005-06-22

Family

ID=27578844

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00990231A Withdrawn EP1242443A4 (fr) 1999-12-23 2000-12-26 Nouveaux acides nucleiques et polypeptides

Country Status (3)

Country Link
EP (1) EP1242443A4 (fr)
CA (1) CA2402563A1 (fr)
WO (1) WO2001053312A1 (fr)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2577799A (en) 1998-02-09 1999-08-23 Human Genome Sciences, Inc. 45 human secreted proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
ES2290834T3 (es) * 1999-03-08 2008-02-16 Genentech, Inc. Secuencias de genes amplificados en tumores y sus usos diagnosticos.
US7465785B2 (en) 1999-03-08 2008-12-16 Genentech, Inc. Polypeptide encoded by a nucleic acid over-expressed in melanoma
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2000073468A1 (fr) 1999-05-28 2000-12-07 Immunex Corporation Nouvelles kinases humaines et murines
EP1621620A3 (fr) * 1999-09-01 2006-05-10 Genetech, Inc. Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
CA2492070A1 (fr) * 1999-12-01 2001-06-07 Kevin P. Baker Polypeptides pro4329 marqueurs de tumeurs du poumon et acides nucleiques codant lesdits polypeptides
US7423127B2 (en) * 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
ATE435277T1 (de) * 2000-02-11 2009-07-15 Millennium Pharm Inc 18477, eine menschliche proteinkinase und deren verwendung
US6479270B1 (en) 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2001235696A1 (en) * 2000-02-17 2001-08-27 Aventis Pharma S.A. Compositions useful for regulating parkin gene activity
AU4540701A (en) * 2000-03-02 2001-09-12 Curagen Corp G12l, a novel gene associated with the thermal response
US20020111307A1 (en) * 2000-06-23 2002-08-15 Glucksmann Maria Alexandra 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof
US20040214758A1 (en) 2000-03-24 2004-10-28 Meyers Rachel E. Novel human hydrolase family members and uses thereof
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
ATE486089T1 (de) * 2000-03-31 2010-11-15 Aventis Pharma Inc Nuklearfaktor kb induzierender faktor
WO2001079467A2 (fr) * 2000-04-12 2001-10-25 The United States Of America, As Represented By Secretary Of The Department Of Health & Human Services Identification d'une nouvelle nadph-oxydase renale
AU2001255421B2 (en) * 2000-04-14 2007-08-23 Gerardo Gamba Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
WO2001081559A2 (fr) * 2000-04-26 2001-11-01 Millennium Pharmaceuticals, Inc. 26335, serine/threonine dehydratase humaine et ses utilisations
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
US20020123097A1 (en) * 2000-09-19 2002-09-05 Millennium Pharmaceuticals, Inc. 63760, a novel human transporter and uses thereof
US6461846B2 (en) 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10027170A1 (de) * 2000-05-31 2001-12-13 Schering Ag Humanes PEM als Target für die Fertilitätskontrolle
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
AU2001268570A1 (en) * 2000-06-16 2001-12-24 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
FR2810673B1 (fr) * 2000-06-26 2004-10-08 Univ Toulouse Dynamine mitochondriale humaine msp1 et son utilisation en therapeutique
AU2001273148A1 (en) * 2000-06-30 2002-01-14 Millennium Pharmaceuticals, Inc. 57658, a human uridine kinase and uses thereof
WO2002006331A2 (fr) * 2000-07-18 2002-01-24 Millennium Pharmaceuticals, Inc. 14087, nouvelle molecule de serine protease, et utilisations associees
AU2001277202A1 (en) * 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-ras/rerg protein and related reagents and methods of use thereof
CA2417087A1 (fr) * 2000-08-01 2002-02-07 Oregon Health And Science University Gene codant pour des proteines d'enveloppe se liant a l'adn mammalien et utilisations dudit gene
WO2002010217A2 (fr) 2000-08-02 2002-02-07 The Johns Hopkins University Profils d'expression de cellules endotheliales
WO2002012339A2 (fr) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Integrines
CN1310942C (zh) * 2000-08-04 2007-04-18 路德维希癌症研究院 校正基因
EP2022797A3 (fr) * 2000-08-28 2011-11-09 Agensys, Inc. Acide nucléique et protéine correspondante intitulée 85P1B3 utile dans le traitement et la détection du cancer
WO2002018566A2 (fr) * 2000-08-31 2002-03-07 Bayer Aktiengesellschaft Regulation d'enzyme de type l-asparaginase humaine
WO2002018424A2 (fr) * 2000-09-01 2002-03-07 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
AU2001287448A1 (en) 2000-09-01 2002-03-13 The Governing Council Of The University Of Toronto Proteins related to schizophrenia and uses thereof
WO2002026945A2 (fr) * 2000-09-27 2002-04-04 Bayer Aktiengesellschaft Regulation d'une enzyme humaine de type aminotransferase
BR0114383A (pt) * 2000-09-27 2005-04-12 Millennium Pharm Inc Interatuadores de canais de potássio e aplicações dos mesmos
WO2002026957A2 (fr) * 2000-09-28 2002-04-04 Bayer Aktiengesellschaft Regulation de la serine protease humaine
GB0024086D0 (en) * 2000-10-02 2000-11-15 Inpharmatica Ltd Proteinase
US6911336B2 (en) * 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
AUPR121300A0 (en) * 2000-11-03 2000-11-30 Monash University Cell division autoantigen (CDA) polypeptides, gene sequences and uses thereof
AU2002237733A1 (en) * 2000-11-07 2002-06-18 Board Of Regents, The University Of Texas System Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
CA2429376A1 (fr) * 2000-11-16 2002-10-17 Emory University Regulateurs d'oxygenase mitogeniques
AU2002224853A1 (en) * 2000-11-17 2002-05-27 Bayer Aktiengesellschaft A human trna-specific adenosine deaminase
EP1209229A1 (fr) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gène impliqué dans la schizophrénie
EP1395657B1 (fr) 2000-12-05 2007-04-18 Wisconsin Alumni Research Foundation Recepteur de la toxine du anthracis
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JPWO2002050269A1 (ja) * 2000-12-21 2004-04-22 株式会社ジェノックス創薬研究所 アレルギー性疾患の検査方法
WO2002062948A2 (fr) * 2000-12-22 2002-08-15 Millennium Pharmaceuticals, Inc. 25828, nouvelle aminopeptidase humaine et utilisations associees
AU2002238483A1 (en) * 2001-01-03 2002-07-16 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
AUPR278301A0 (en) 2001-01-31 2001-02-22 Bionomics Limited A novel gene
WO2002057444A1 (fr) * 2001-01-22 2002-07-25 Shinae Kondoh Genes associes a l'apoptose humaine et proteines produites associees a l'apoptose humaine
AU2002305921A1 (en) * 2001-01-22 2002-10-08 Millennium Pharmaceuticals, Inc. Fbh58295fl, a novel human amino acid transporter and uses thereof
US6686176B2 (en) * 2001-01-23 2004-02-03 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
WO2002072830A2 (fr) * 2001-02-09 2002-09-19 Incyte Genomics, Inc. Proteines associees a la croissance, a la differenciation et a la mort cellulaire
AU2002247716A1 (en) * 2001-02-14 2002-08-28 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
EP1575984A4 (fr) 2001-02-16 2006-09-06 Bristol Myers Squibb Co Identification et clonage d'un nouveau gene humain, ret16, jouant un role dans la cascade de signalisation intracellulaire cascade
US6461843B1 (en) 2001-02-16 2002-10-08 Applera Corporation Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
EP1521824A2 (fr) * 2001-03-16 2005-04-13 Incyte Genomics, Inc. Acide nucleique et proteines associees
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US20020173639A1 (en) * 2001-03-26 2002-11-21 Friddle Carl Johan Novel human asparaginases and polynucleotides encoding the same
US6867019B2 (en) * 2001-03-27 2005-03-15 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002078729A1 (fr) 2001-03-29 2002-10-10 Celltech R & D, Inc. Compositions et methodes de diagnostic ou de traitement du psoriasis
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
WO2002083887A2 (fr) * 2001-04-12 2002-10-24 Bayer Aktiengesellschaft Regulation de la proteine de type methionine aminopeptidase humaine
US20030022205A1 (en) * 2001-05-09 2003-01-30 Millennium Pharmaceuticals, Inc. 98359, a sodium channel beta 4 subunit, and uses therefor
DE60239087D1 (de) * 2001-05-30 2011-03-10 Chiba Prefecture Aus einem Neuroblastom isolierte Nukleinsäuren
CA2453075A1 (fr) * 2001-07-06 2003-01-16 Incyte Genomics, Inc. Enzymes de metabolisation de medicaments
US20040219551A1 (en) * 2001-07-09 2004-11-04 Petersen Ole William Epsti1, a novel gene induced by epithelial-stromal interaction in human breast cancer
CA2453653A1 (fr) * 2001-07-26 2003-02-06 Genset S.A. Polynucleotides et polypeptides gmg-2 et leurs utilisations
FR2828209A1 (fr) * 2001-08-01 2003-02-07 Cytomics Systems Acides nucleiques codant de nouvelles proteines a domaine hect, leurs utilisations en diagnostics et en therapie
US7413870B2 (en) * 2001-08-01 2008-08-19 Rigel Pharmaceuticals, Incorporated SAK: modulation of cellular proliferation for treatment of cancer
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
JP4102898B2 (ja) 2001-08-23 2008-06-18 独立行政法人科学技術振興機構 造血幹細胞増殖調節因子及びそれをコードするポリヌクレオチド
JP2003135063A (ja) * 2001-08-24 2003-05-13 Chiba Prefecture 新規な遺伝子ｎｅｄｌ−１
CA2459013C (fr) * 2001-08-27 2011-01-04 Japan Science And Technology Agency Proteines pouvant commander la migration cellulaire et la mort cellulaire
US20030073118A1 (en) * 2001-08-31 2003-04-17 Millennium Pharmaceuticals, Inc. MID 9002, a human sulfatase family member and uses therefor
AU2008201998B2 (en) * 2001-09-18 2010-12-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
KR101008758B1 (ko) * 2001-09-18 2011-01-14 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
JP4232423B2 (ja) * 2001-09-28 2009-03-04 第一三共株式会社 新規ユビキチン特異プロテアーゼ
EP1451213A4 (fr) * 2001-10-03 2005-11-16 Immunex Corp Polypeptides des cytokines humaine et murine
WO2003038093A2 (fr) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation de la l-serine deshydratase humaine
WO2003038113A2 (fr) * 2001-10-31 2003-05-08 Millennium Pharmaceuticals, Inc. Methodes et compositions destinees au traitement et au diagnostic de troubles lies a la proliferation cellulaire au moyen de 25943
US7166713B2 (en) * 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
JP2005514013A (ja) * 2001-12-19 2005-05-19 ミレニアム・ファーマシューティカルズ・インコーポレイテッド １４６５、１５８７、２１４６、２２０７、３２８３８、３３６、および５２９０８を使用して疼痛および有痛性障害を処置する際の方法および組成物
WO2003057867A2 (fr) * 2002-01-10 2003-07-17 Bayer Healthcare Ag Regulation de l'enzyme de liaison a l'amp, du type coa ligase d'acide gras humaine
AU2003235632A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003210158A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003205174A1 (en) * 2002-01-17 2003-09-02 Incyte Genomics, Inc. Molecules for disease detection and treatment
WO2003072773A1 (fr) * 2002-02-08 2003-09-04 Seikagaku Corporation Proteine fusionnee ayant une activite de glucuronyltransferase
JP2003250550A (ja) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd 脂肪細胞分化関連遺伝子およびタンパク質
GB0206684D0 (en) * 2002-03-21 2002-05-01 Babraham Inst Novel proteins
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
WO2003080825A2 (fr) * 2002-03-27 2003-10-02 Bayer Healthcare Ag Regulation de kinase humaine inductible par bmp-2
US20050216961A1 (en) * 2002-03-28 2005-09-29 Delaney Allen D Cancer associated protein kinases and their uses
CA2480386A1 (fr) * 2002-03-29 2003-10-09 National Institute Of Advanced Industrial Science And Technology Nouvelles galactose transferases et leurs peptides, et acide nucleique codant pour lesdites transferases
WO2003082342A1 (fr) * 2002-04-01 2003-10-09 National Institute Of Advanced Industrial Science And Technology Utilisation du gene k1aa0172 pour le traitement et le diagnostic de maladies et decouverte de medicaments
MXPA04010092A (es) * 2002-04-16 2004-12-13 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
AU2003233124A1 (en) * 2002-04-29 2003-11-17 Clinigenetics Assays for identifying cholesterol - lowering molecules
US7009038B2 (en) * 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
AU2003238178A1 (en) 2002-05-29 2003-12-12 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Pancreas-specific proteins
CA2488775C (fr) * 2002-06-07 2011-04-12 Arthron Limited Modele animal transgenique de fcyriia pour affection auto-immune
JP2006505249A (ja) * 2002-06-13 2006-02-16 ワイス・ホールディングズ・コーポレイション 炎症遺伝子活性およびコレステロール生合成の阻害剤
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
US20060189518A1 (en) * 2002-06-26 2006-08-24 Takeda Pharmaceutical Company Limited Preventing/remedies for cancer
EP1541677A4 (fr) * 2002-07-10 2007-06-27 Takeda Pharmaceutical Nouvelles proteines et leur utilisation
JP2004097199A (ja) * 2002-07-15 2004-04-02 Keio Gijuku 腫瘍抗原のスクリーニング方法
WO2004009622A2 (fr) * 2002-07-19 2004-01-29 Cellzome Ag Complexes de proteiniques de reseaux cellulaires fondant le developpement du cancer et d'autres maladies
WO2004009783A2 (fr) 2002-07-24 2004-01-29 New York University Oncogene rgr humain et produits de transcription de celui-ci detectes dans les affections malignes liees aux lymphocytes t, anticorps diriges contre les polylpeptides codes et methodes d'utilisation
GB0217631D0 (en) * 2002-07-30 2002-09-11 Inpharmatica Ltd Proteins
AU2003251656A1 (en) * 2002-07-30 2004-02-23 Bayer Healthcare Ag Regulation of human methyltransferase
WO2004020620A1 (fr) * 2002-08-13 2004-03-11 Bayer Healthcare Ag Regulation de l'esterase humaine
US20070269800A9 (en) * 2002-08-28 2007-11-22 Heinz Von Der Kammer Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
EP1396544A1 (fr) * 2002-09-06 2004-03-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Acides nucléiques codant pour des déhydrogénases thyroidiennes humaines
CA2498739A1 (fr) * 2002-09-12 2004-03-25 Pharmexa A/S Immunisation contre la ghreline autologue
WO2004032614A2 (fr) * 2002-09-13 2004-04-22 Ingenium Pharmaceuticals Ag Genes de la chaine lourde 1 de dyneine cytoplasmiques, produits d'expression, modele animal non humain : utilisation pour les maladies neurologiques humaines
WO2004028558A1 (fr) * 2002-09-27 2004-04-08 Takeda Pharmaceutical Company Limited Agents préventifs/remèdes contre les maladies neurodégénératives
US7560537B2 (en) * 2002-09-30 2009-07-14 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
US7662917B2 (en) 2002-09-30 2010-02-16 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
WO2004039980A1 (fr) * 2002-10-30 2004-05-13 Cancer Research Technology Limited Methodes de traitement et compositions
WO2004039974A1 (fr) * 2002-10-30 2004-05-13 Takeda Pharmaceutical Company Limited Nouvelle proteine et son adn
MXPA05005385A (es) * 2002-11-21 2005-08-03 Wyeth Corp Composicion y metodo para tratar lupus nefritico.
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
WO2004058971A1 (fr) * 2002-12-24 2004-07-15 Peking University Genes se rapportant a un cancer humain, produits codes par ces genes, et applications correspondantes
US20050015821A1 (en) * 2003-02-21 2005-01-20 Phenomix Corporation Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
JP4445291B2 (ja) * 2003-03-10 2010-04-07 武田薬品工業株式会社 新規タンパク質およびそのｄｎａ
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1464651A1 (fr) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Protéine associée à la distrophine (Drop1) utilisée comme marqueur por le cancer
US7829682B1 (en) * 2003-04-30 2010-11-09 Incyte Corporation Human β-adrenergic receptor kinase nucleic acid molecule
CN1244595C (zh) * 2003-05-14 2006-03-08 中国科学院上海生命科学研究院 一种肿瘤抑制蛋白及其应用
WO2005017155A1 (fr) * 2003-06-18 2005-02-24 Chugai Seiyaku Kabushiki Kaisha Transporteur du fucose
FR2843753A1 (fr) * 2003-06-20 2004-02-27 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
JPWO2004113532A1 (ja) * 2003-06-21 2006-08-03 繁樹 東山 細胞増殖抑制剤スクリーニング用タンパク質及び細胞増殖抑制剤のスクリーニング方法並びに細胞増殖抑制剤
WO2005003336A2 (fr) * 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Choline-phosphotransferases et ethanolamine-phosphotransferases nouvellement identifiees
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
EP1699478A2 (fr) * 2003-09-23 2006-09-13 Meyer Pharmaceuticals, LLC Traitement d'une inflammation au moyen d'un agent biologique provoquant la liberation de recepteurs de cytokines par des cellules
JP2005168338A (ja) * 2003-12-09 2005-06-30 Japan Science & Technology Agency 新規タンパク質カルフォグリン、これをコードする遺伝子、薬剤、及び標的物質
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
JP4757194B2 (ja) * 2004-03-19 2011-08-24 ジェノミディア株式会社 血管内皮増殖抑制遺伝子
GB0407587D0 (en) * 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens
WO2006033460A1 (fr) * 2004-09-24 2006-03-30 Oncotherapy Science, Inc. PROCÉDÉ SERVANT À DIAGNOSTIQUER DES CANCERS DES POUMONS NON À PETITES CELLULES PAR L'ACTIVITÉ DE L'ARNt-DIHYDROURIDINE SYNTHÉTASE DE URLC8
JP2008520251A (ja) * 2004-11-22 2008-06-19 ワイス 固形腫瘍の予後および処置のための方法およびシステム
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
EP1856278A2 (fr) 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Methode de diagnostic du cancer de la vessie
EP1734118A1 (fr) * 2005-06-15 2006-12-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Identification de gènes modulateurs de la voie de signalisation JAK/STAT par criblage du génome à l'aide d'ARNi
WO2007028631A1 (fr) * 2005-09-09 2007-03-15 H. Lundbeck A/S Facteur de risque genetique de troubles neurodeveloppementaux et leurs complications
US20070071755A1 (en) * 2005-09-27 2007-03-29 David Balasundaram Novel nucleolar GTPases and method for controlling proliferation of cells
WO2007088639A1 (fr) * 2006-02-01 2007-08-09 Hiroshima University Proteine substrat de la kinase de la phase m et son utilisation
EP1815863A1 (fr) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Utilisation des agopistes TLR3 pour le traitement des maladies neurodégénératives
US7884078B2 (en) 2006-02-10 2011-02-08 Massachusetts Institute Of Technology CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists
US8933209B2 (en) * 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
EP2125775A4 (fr) 2007-03-01 2011-07-13 Cedars Sinai Medical Center Polymères antioxydants contenant des fragments [1,2]-dithiolane et leurs utilisations
US8664359B2 (en) * 2007-06-03 2014-03-04 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2027889A1 (fr) 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nouveau facteur de viabilité neuronale et son utilisation
US9028874B2 (en) 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
US7833721B2 (en) 2008-03-14 2010-11-16 Exagen Diagnostics, Inc. Biomarkers for inflammatory bowel disease and irritable bowel syndrome
US8603531B2 (en) 2008-06-02 2013-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of NSAIDs
JP5564512B2 (ja) 2008-11-24 2014-07-30 セダーズ−シナイ メディカル センター 抗酸化カンプトセシン誘導体及びその抗酸化、抗新生物ナノスフェア
KR20110128316A (ko) 2009-02-20 2011-11-29 가니메드 파마슈티칼스 아게 암의 진단 및 치료를 위한 방법 및 조성물
US9487584B2 (en) 2009-11-11 2016-11-08 Ganymed Pharmaceuticals Ag Antibodies specific for claudin 6 (CLDN6)
EP2404936A1 (fr) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Thérapie du cancer utilisant des anticorps in vivo dirigés sur la cible CLDN6
EP3421496A1 (fr) 2011-05-13 2019-01-02 Ganymed Pharmaceuticals GmbH Anticorps pour le traitement du cancer exprimant du claudin 6
KR101949186B1 (ko) * 2011-05-19 2019-02-18 도레이 카부시키가이샤 면역 유도제
WO2013104798A1 (fr) * 2012-01-12 2013-07-18 Cemm - Center For Molecular Medicine Of The Austrian Academy Of Sciences Modulateurs de réponses immunitaires
LT2814844T (lt) 2012-02-15 2017-10-25 Novo Nordisk A/S Antikūnai, kurie jungiasi ir blokuoja ekspresuotą ant mieloidinių ląstelių inicijuojantį receptorių 1 (trem-1)
RS57827B1 (sr) 2012-02-15 2018-12-31 Novo Nordisk As Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
US20130288980A1 (en) * 2012-04-02 2013-10-31 Buck Institute For Research On Aging Targeting senescent and cancer cells for selective killing by interference with foxo4
WO2015014376A1 (fr) 2013-07-31 2015-02-05 Biontech Ag Diagnostic et thérapie du cancer impliquant des cellules souches cancéreuses
MX2017000484A (es) 2014-07-17 2017-05-01 Novo Nordisk As Mutagenesis dirigida al sitio anticuerpos receptor desencadenante expresado en las celulas mieloides de tipo 1 (trem-1) para reducir la viscosidad.
EP2977758A1 (fr) 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Procédés et kits pour surveiller la néphropathie membraneuse
WO2016096785A1 (fr) * 2014-12-19 2016-06-23 F. Hoffmann-La Roche Ag Identification de substrats de transglutaminase et leurs utilisations
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
JP6757319B2 (ja) 2014-12-19 2020-09-16 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 微生物トランスグルタミナーゼ、その基質、およびその使用方法
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
CR20200607A (es) 2016-04-21 2021-01-20 Immatics Biotechnologies Gmbh INMUNOTERAPIA CONTRA EL MELANOMA Y OTROS TIPOS DE CÁNCER (Divisional 2018-551)
CA3021159A1 (fr) 2016-04-21 2017-10-26 Immatics Biotechnologies Gmbh Immunotherapie contre le melanome et d'autres cancers
EA202092302A1 (ru) 2018-04-02 2021-02-02 Бристол-Майерс Сквибб Компани Антитела к trem-1 и их применения
GB201807831D0 (en) * 2018-05-15 2018-06-27 Univ College Cardiff Consultants Ltd Cancer Vaccine
WO2021173847A1 (fr) * 2020-02-27 2021-09-02 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Cobra1/nelf-b utilisé en tant que renforçateur d'efficacité d'une thérapie à base de lymphocytes t cd8+

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (fr) * 1998-03-10 1999-09-16 Genentech, Inc. Nouveaux polypeptides et acides nucleiques les codant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175095A (en) * 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (fr) * 1998-03-10 1999-09-16 Genentech, Inc. Nouveaux polypeptides et acides nucleiques les codant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JACOBS K A ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, no. 1-2, 1 October 1997 (1997-10-01), pages 289 - 296, XP004570106, ISSN: 0378-1119 *
See also references of WO0153312A1 *

Also Published As

Publication number Publication date
CA2402563A1 (fr) 2001-07-26
WO2001053312A1 (fr) 2001-07-26
WO2001053312A8 (fr) 2002-06-20
EP1242443A1 (fr) 2002-09-25

Similar Documents

Publication Publication Date Title
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1239039A4 (fr) Nouveau polypeptide et son adn
AU3511100A (en) Novel nucleic acids and polypeptides
HUP0201660A2 (en) Novel polypeptide and dna thereof
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
AU1453601A (en) Novel polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/11 B

Ipc: 7C 07K 14/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 07H 21/04 A

Ipc: 7C 07K 14/435 B

Ipc: 7C 12N 15/70 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060111